Effects of Mesenchymal Stem Cell Treatment on Systemic Cytokine Levels in a Phase 1 Dose Escalation Safety Trial of Septic Shock Patients*

OBJECTIVES: Cellular Immunotherapy for Septic Shock is the first-in-human clinical trial evaluating allogeneic mesenchymal stem/stromal cells in septic shock patients. Here, we sought to determine whether plasma cytokine profiles may provide further information into the safety and biological effects...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Crit Care Med
Main Authors: Schlosser, Kenny, Wang, Jia-Pey, dos Santos, Claudia, Walley, Keith R., Marshall, John, Fergusson, Dean A., Winston, Brent W., Granton, John, Watpool, Irene, Stewart, Duncan J., McIntyre, Lauralyn A., Mei, Shirley H. J.
Formato: Artigo
Idioma:Inglês
Publicado em: Lippincott Williams & Wilkins 2019
Assuntos:
Clinical Investigations
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6629173/
https://ncbi.nlm.nih.gov/pubmed/30720538
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CCM.0000000000003657
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados